Solitary Fibrous Tumors of the Chest: Case Series from a Portuguese Center
DOI:
https://doi.org/10.20344/amp.23767Keywords:
Solitary Fibrous Tumor, PleuralAbstract
The solitary fibrous tumor is a rare mesenchymal tumor with predilection for the pleura. Most times it is an incidental diagnosis. Surgery is the recommended treatment. Most solitary fibrous tumors (SFTs) exhibit indolent behavior; however, 10% to 25% may experience recurrence. The aim of this retrospective analysis is to characterize their presentation, therapeutic approach and recurrence and was conducted at the Pulmonary Oncology Department in Unidade Local de Saúde Santa Maria, in Lisbon, Portugal, between May 2013 and December 2023. We identified nine patients, 66,7% male, median age 66 years. The average tumor size was 14.5 cm; 88.9% located in the pleura. Surgical intervention was proposed for eight patients, of whom seven underwent the procedure. Four patients had disease recurrence, three underwent new surgery and one died. One of these three patients underwent post-operative radiotherapy. Again, these three patients suffered a relapse, one underwent surgery and two started systemic therapy. At the time of cut-off, five patients were alive, and four were progression-free. The solitary fibrous tumor is a rare and underdiagnosed entity, which justifies the small number of patients, and its malignant potential is poorly recognized. Our findings are consistent with those reported in the existing literature; however, we observed a higher proportion of tumors exhibiting malignant characteristics. The high prevalence of recurrence is explained by the fact that only complex or previously recurrent cases are referred for discussion at our center.
Downloads
References
Klemperer P, Rabin CB. Primary neoplasms of the pleura: a report of five cases. Arch Pathol. 1931;11:385-412.
Davanzo B, Emerson RE, Lisy M, Koniaris LG, Kays JK. Solitary fibrous tumor. Transl Gastroenterol Hepatol. 2018;3:94.
Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N. A comprehensive review on solitary fibrous tumor: new insights for new horizons. Cancers. 2021;13:2913.
Tariq MU, Din NU, Abdul-Ghafar J, Park Y. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagn Pathol. 2021;16:32.
Gao X, Zhang J, Qian Z, Liu L, Wang G, Song Y, et al. Malignant solitary fibrous tumor of the pleura: a narrative review of clinical characteristics, diagnosis and therapeutic options. Respir Med Res. 2024;86:100961.
Bosman FT, Lakhani SR, Ohgaki H. WHO classification of tumours of the lung, pleura, thymus and heart. Lyons: International Agency for Research on Cancer (IARC); 2015.
Mercer RM, Wigston C, Banka R, Cardillo G, Benamore R, Nicholson AG, et al. Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis. ERJ Open Res. 2020;6:00055-2020.
England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640-58.
Lococo F, Cesario A, Cardillo G, Filosso P, Galetta D, Carbone L, et al. Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol. 2012;7:1698-706.
Cardillo G, Carbone L, Carleo F, Masala N, Graziano P, Bray A, et al. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg. 2009;88:1632-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

